BioSpecifics Technologies Corp. Reports Second Quarter 2010 Financial Results

Friday, August 6, 2010 News on IT in Healthcare
Email Print This Page Comment
Font : A-A+

BioSpecifics Technologies Corp.

Selected Consolidated Balance Sheet Data

(Unaudited)

June 30,

December 31,

2010

2009

Cash and cash equivalents

$             5,304,216

$             3,950,389

Short term investments

               4,548,541

               4,548,541

Accounts and income tax receivable, net

               1,027,787

               1,712,220

Working capital

               5,983,286

               5,768,760

Total assets

             12,483,363

             11,748,478

Long-term liabilities

                  932,170

               1,150,721

Total stockholders' equity

               6,484,085

               6,092,107



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook